Everna is rethinking the big-pharma approach to drugs and supplements targeting age related disease using both FDA and non-FDA solutions. Developer of a class of drugs designed to have a disease-modifying effect on several major diseases of aging. The company’s drugs are stem cell models, enabling users to fight neurodegenerative, atherosclerosis, and other diseases responsible for the largest number of deaths.